bluuebunny/crossref_metadata_2025_split huggingface dataset:
Chemisches Recycling von gemischten Kunststoffabfällen als ergänzender Recyclingpfad zur Erhöhung der Recyclingquote
Authors: Lechleitner A. , Schwabl D. , Schubert T. , Bauer M. , Lehner M. 
Published: November 2019

Zusammenfassung
Kunststoffabfälle, speziell Verpackungsabfälle, liegen oft als Gemische mit hohem Verschmutzungsgrad vor. Die werkstoffliche Verwertung wird dadurch enorm erschwert, da die Sortierung und Reinigung dieser Fraktionen in vielen Fällen nicht ökonomisch sinnvoll oder technisch umsetzbar sind. Um diese Materialströme dennoch rohstofflich rezyklieren zu können, bietet das chemische Recycling eine vielversprechende Methode durch die Rückgewinnung von Einsatzstoffen für die Kunst- und Kraftstoffproduktion sowie für die petrochemische Industrie. Durch das Einwirken von Wärme, Katalysatoren und Lösungsmitteln werden dabei die Polymerketten in kürzere Einheiten bis hin zu Monomeren aufgespalten. Die dabei gewonnenen Kohlenwasserstoffe können dem Stoffkreislauf erneut zugeführt werden, um primäre Ressourcen zu ersetzen. Diese Technologien weisen eine hohe Toleranz gegenüber Störstoffen und Sortenunreinheiten auf und sind deshalb besonders attraktive Optionen für die Verwertung von verunreinigten Verpackungsabfällen. In den letzten 40 Jahren wurden hierzu verschiedene Ansätze zur Solvolyse und Pyrolyse mit und ohne Katalysator verfolgt, die zugrunde liegenden Mechanismen untersucht sowie zahlreiche Reaktorsysteme und Prozesswege entwickelt. Ein Überblick über die chemischen Grundlagen, die entwickelten Verfahren und deren Werdegang gibt Aufschluss über die Chancen und Problematiken des Feedstockrecyclings als ergänzende Maßnahme zum werkstofflichen Recycling. Weiters werden die neuesten Forschungs- und Entwicklungsaktivitäten dargestellt, um den heutigen Entwicklungsstand und zukünftige Trends abzubilden und aufzuzeigen, dass das chemische Recycling eine potente Option zur Rückgewinnung von Rohstoffen und Schonung von Ressourcen darstellt.
Spinal surgery complications: an unsolved problem—Is the World Health Organization Safety Surgical Checklist an useful tool to reduce them?
Authors: Barbanti-Brodano Giovanni , Griffoni Cristiana , Halme Jarkko , Tedesco Giuseppe , Terzi Silvia , Bandiera Stefano , Ghermandi Riccardo , Evangelisti Gisberto , Girolami Marco , Pipola Valerio , Gasbarrini Alessandro , Falavigna Asdrubal 
Published: November 2019

Abstract

Purpose
To investigate whether the World Health Organization Safety Surgical Checklist (SSC) is an effective tool to reduce complications in spinal surgery.

Methods
We retrospectively evaluated the clinical and radiological charts prospectively collected from patients who underwent a spinal surgery procedure from January 2010 to December 2012. The aim of this study was to compare the incidence of complications between two periods, from January to December 2010 (without checklist) and from January 2011 and December 2012 (with checklist), in order to assess the checklist’s effectiveness.

Results
The sample size was 917 patients with an average of 30-month follow-up. The mean age was 52.88 years. The majority of procedures were performed for oncological diseases (54.4%) and degenerative diseases (39.8%). In total, 159 complications were detected (17.3%). The overall incidence of complications for trauma, infectious pathology, oncology, and degenerative disease was 22.2%, 19.2%, 18.4%, and 15.3%, respectively. No correlation was observed between the type of pathology and the complication incidence. We observed a reduction in the overall incidence of complications following the introduction of the SSC: In 2010 without checklist, the incidence of complications was 24.2%, while in 2011 and 2012, following the checklist introduction, the incidence of complications was 16.7% and 11.7%, respectively (mean 14.2%).

Conclusions
The SSC seems to be an effective tool to reduce complications in spinal surgery. We propose to extend the use of checklist system also to the preoperative and postoperative phases in order to further reduce the incidence of complications.

Graphic abstract
These slides can be retrieved under Electronic Supplementary Material.
Sleep symptoms and long-term outcome in adolescents with major depressive disorder: a naturalistic follow-up study
Authors:   The Adolescent Depression Study Group, Urrila Anna S. , Kiviruusu Olli , Haravuori Henna , Karlsson Linnea , Viertiö Satu , Suvisaari Jaana , Marttunen Mauri 
Published: November 2019

Abstract
Sleep abnormalities in major depressive disorder (MDD) have been suggested to represent a vulnerability trait, which might predispose the individual to long-term psychiatric morbidity. In this study, we sought to assess whether the presence of sleep symptoms among adolescents with MDD is associated with poorer long-term outcome in young adulthood during naturalistic follow-up. Adolescent outpatients diagnosed with MDD (n = 166; age 13–19 years, 17.5% boys) were followed up during 8 years in naturalistic settings. N = 112 adolescents (16.1% boys) completed the 8-year assessment. Sleep symptoms and psychosocial functioning were assessed with structured clinical interviews, and depressive and anxiety symptoms with questionnaires. The severity of sleep symptoms at baseline was not associated with worse outcome at 8 years in terms of any of the outcome measures tested. In particular, the presence of a disturbed sleep–wake rhythm at baseline was associated with a more favourable outcome at 8 years: less depression and anxiety symptoms and higher level of psychosocial functioning. The presence of sleep symptoms in young adulthood was associated with the presence of current depression and anxiety symptoms and poorer psychosocial functioning. The presence of sleep symptoms at follow-up seems to be state-dependent: they are observed in conjunction with other psychiatric symptoms. Contrary to our hypothesis, our results suggest that sleep complaints among adolescents with MDD do not lead to poorer long-term clinical outcome in young adulthood. The link between sleep–wake rhythm disturbance and better long-term outcome needs to be confirmed and examined in detail in further studies, but here we speculate about possible explanations.
The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontamination
Authors: van Hout Denise , Janssen Axel B. , Rentenaar Rob J. , Vlooswijk Judith P.M. , Boel C.H. Edwin , Bonten Marc J.M. 
Published: November 2019

Abstract
The objective of this study was to determine the value of using SuperPolymyxin™ selective medium (ELITech Group, Puteaux, France) in addition to conventional non-selective inoculation methods in the detection of acquired colistin resistance in a Dutch intensive care unit (ICU) that routinely uses selective decontamination of the digestive tract (SDD). We performed a cross-sectional study with prospective data collection in a tertiary-care ICU. All consecutive surveillance rectal swabs of ICU-patients receiving SDD were included and cultured in an observer-blinded approach using (1) a conventional culture method using non-selective media and (2) SuperPolymyxin™ selective medium. MIC values for colistin of non-intrinsically colistin-resistant Gram-negative isolates were determined with broth microdilution (BMD) using Sensititre™ and colistin resistance was confirmed using BMD according to EUCAST guidelines. One thousand one hundred five rectal swabs of 428 unique ICU-patients were inoculated using both culture methods, yielding 346 and 84 Gram-negative isolates for BMD testing with the conventional method and SuperPolymyxin™ medium, of which 308 and 80 underwent BMD, respectively. The number of identified rectal carriers of isolates with acquired colistin resistance was 3 (0.7%) for the conventional method, 4 (0.9%) for SuperPolymyxin™, and 5 (1.2%) for both methods combined. The number of isolates with acquired colistin resistance was 4 (1.0%) for the conventional method, 8 (2.1%) for SuperPolymyxin™ and 9 (2.3%) for both methods combined. In a surveillance setting of low prevalence of acquired colistin resistance in patients that receive SDD in a Dutch tertiary-care ICU, SuperPolymyxin™ had a higher diagnostic yield than conventional inoculation methods, but the combination of both had the highest diagnostic yield.
Validation of Emission Spectroscopy Gas Temperature Measurements Using a Standard Flame Traceable to the International Temperature Scale of 1990 (ITS-90)
Authors: Sutton Gavin , Fateev Alexander , Rodríguez-Conejo Miguel A. , Meléndez Juan , Guarnizo Guillermo 
Published: November 2019

Abstract
Accurate measurement of post-flame temperatures can significantly improve combustion efficiency and reduce harmful emissions, for example, during the development phase of new internal combustion engines and gas turbine combustors. Non-perturbing optical diagnostic techniques are capable of measuring temperatures in such environments but are often technically complex and validation is challenging, with correspondingly large uncertainties, often as large as 2 % to 5 % of temperature. This work aims to reduce these uncertainties by developing a portable flame temperature standard, calibrated via the Rayleigh scattering thermometry technique, traceable to ITS-90, with an uncertainty of 0.5 % of temperature (k = 1). By suitable burner selection and accurate gas flow control, a stable, square, flat flame with uniform post-flame species and temperature is realised. Following development, the standard flame is used to validate two IR emission spectroscopy systems, both measuring the line-integrated emission spectra in the post-flame region. The first utilises a Hyperspectral imaging FTIR spectrometer capable of measuring 2D species and temperature maps and the second, a high-precision single line-of-sight FTIR spectrometer. In the central post-flame region, the agreement between the Rayleigh and FTIR temperatures is within the combined measurement uncertainties and amounts to 1 % (k = 1) of temperature.
What moderates the attainment gap? The effects of social identity incompatibility and practical incompatibility on the performance of students who are or are not Black, Asian or Minority Ethnic
Authors: Frings Daniel , Gleibs Ilka H. , Ridley Anne M. 
Published: November 2019

AbstractA successful journey through higher education is, for many, a once in a lifetime opportunity for social mobility. Unfortunately, one notable feature of higher education systems is that students from some backgrounds do not achieve the same academic attainments as do others. The current study tests the role of one particular set of processes: social identity (in)compatibility on academic performance. Participants were recruited at two time points from a pool of first year undergraduates at a modern London University (N = 215) of which 40.1% were classed as Black, Asian or Minority Ethnic (BAME), 57.1% as non-BAME and 2.8% did not provide this information. A prospective design was employed: Alongside demographic data, measures at the start of the academic year consisted of measures of student and ethnic identity, and both practical and identity incompatibility. At the end of the academic year, average marks achieved were gained for each student from the university’s registry system. Results indicate that BAME students had equal levels of student identity to non-BAME students, but higher levels of ethnic identity. They also typically experienced higher levels of both practical and identity incompatibility. Finally, BAME students had lower attainment than did non-BAME students. Both practical and identity incompatibility appeared to moderate this effect. However, contrary to predictions, it was only under conditions of low and medium levels of incompatibility that BAME students attained lower marks than their non-BAME peers. The theoretical and practical implications of these findings are discussed.
Discriminative Characteristics of Marginalised Novel Psychoactive Users: a Transnational Study
Authors: Felvinczi Katalin , Benschop Annemieke , Urbán Róbert , Van Hout Marie Claire , Dąbrowska Katarzyna , Hearne Evelyn , Henriques Susana , Kaló Zsuzsa , Kamphausen Gerrit , Silva Joana Paula , Wieczorek Łukasz , Werse Bernd , Bujalski Michal , Demetrovics Zsolt , Korf Dirk 
Published: November 2019

Abstract
New psychoactive substances (NPS) continue to be considered as a major public health concern in many European countries. The study was implemented within the framework of a transnational project of six European countries (Germany, Hungary, Ireland, Netherlands, Poland, Portugal). Our aim here is to report on the distinct and differentiating characteristics of marginalised NPS users. Three subgroups of a total of 3023 adult NPS users (socially marginalised, night life, online community) were examined regarding their socio-demographic characteristics, substance use, and external motives towards NPS use. Poland and Hungary reported higher rates of NPS use in comparison to traditional controlled drugs. The external/contextual motives did not play a central role in the background of NPS use, the least important motives were alleged legality and non-detectability of these substances. Marginalised (defined as those accessing low threshold harm reduction services) users’ substance use patterns are different from the other two groups in terms of showing more intense and riskier drug use. The most important variables which contributed to be categorised as a marginalised NPS user were lower level education, being older, having an unfavourable labour market position and using drugs intravenously. Contextual motives did not play a decisive role in being categorised as a marginalised user when drug use pattern was controlled. These identified discriminative features of marginalised drug users should inform policy makers to develop and implement tailor-made interventions targeting this user group to successfully tackle the elevated public health concerns associated with NPS use.
Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria
Authors: Balic Marija , Hilbe Wolfgang , Gusel Sylvia , Fiegl Michael , Ludwig Heinz , Mayrbäurl Beate , Thaler Josef , Samonigg Hellmut , Hegenbarth Karin , Eisner Florian , Mlineritsch Brigitte , Greil Richard , Schandl Maria Johanna , Weltermann Ansgar , Petzer Andreas , Fuchs David , Stangl Wolfgang , Krippl Peter , Stauder Reinhard , Stöger Herbert 
Published: November 2019

Summary
The purpose of this observational study was to determine the prevalence of comorbid conditions in cancer patients with solid tumours selected for specific treatment at 12 divisions of medical oncology in Austria. Data from 1137 patients were collected using a standardized questionnaire; of these, 1036 datasets were evaluable for further analysis. Data were prospectively collected from patients during an in- or outpatient hospital visit over a 4-month period in 2011. Of these patients 42% had gastrointestinal cancer, 31% had breast cancer, 9% lung cancer and the remaining had urogenital cancer, sarcoma or other types of rare cancers. Around two-thirds of patients had metastatic disease (59%), confined to a single organ site in 55% of patients. A high proportion of patients had a good performance status (Eastern Cooperative Oncology Group [ECOG] 0, 1: 82%). Comorbid conditions were classified according to the Charlson scheme score and were present in 86% of patients with a median age of 64 years. The predominant conditions were cardiovascular diseases (57%), metabolic diseases (44%), endocrinological diseases (30%), gastrointestinal diseases (26%), neurological (23%) and respiratory diseases (23%). As has been reported by others we found a clear association between number of comorbid conditions and age. While 60% of the whole population had at least 2 comorbidities, most patients of the elderly population (89%) had more than three comorbidities. The high proportion of patients with comorbidities and accompanying medication represents a substantial challenge for medical oncologists in selecting the optimal cancer-specific treatment especially in the era of novel targeted and immunotherapies. Comorbid conditions and accompanying comedications require special precautions concerning potential interactions and unexpected adverse reactions from prescribed tumour-specific treatment.
Oilfield metal naphthenate formation and mitigation measures: a review
Authors: Eke William Iheanyi , Victor-Oji Cynthia , Akaranta Onyewuchi 
Published: November 2019

AbstractProcess facilities for the separation of hydrocarbons from produced water in the oilfield are critical to flow assurance, product quality and environmental compliance. The formation of metal naphthenates, which are emulsion stabilizers and equipment foulers, is deleterious to performance and integrity of these processes and facilities. Manual removal of deposits of these organic salts formed at the oil–water interface during separation processes is difficult and expensive; hence, the best operational option is inhibition. The conventional method for the inhibition of metal naphthenates, which relies on suppressing the deprotonation of naphthenic acids by common ion effect, is no longer tenable because it exacerbates internal corrosion problems in topside facilities. Current industry focus is on the development of effective surface active agents for inhibition of naphthenates. There are a plethora of chemical compounds with naphthenate inhibition potential such as sulphonates, phosphate esters, aminated phosphonates and sulphosuccinates, but compatibility issues make the choice of inhibitor a complicated process. In this paper, the drivers and mechanism of oilfield metal naphthenate formation are reviewed. Surfactants for oilfield metal naphthenate inhibition and the mechanisms of inhibition are highlighted with a view to process optimization.
Investigation on cold-formed steel built-up new innovative hat-shaped closed section under bending
Authors: Manikandan P. , Ezhilan A. 
Published: November 2019

Abstract
The objective of this study is to make the experimental and finite element simulations of buckling behaviour of cold-formed steel (CFS) built-up hat-shaped closed section under simply supported end condition subjected to two-point loading. Numerical simulation is carried out using the software ABAQUS. The test result is compared with numerical results and good correlation is achieved. Next, for validation, a series of parametric studies are carried out using the validated numerical model, such as the effect of length, depth, width, thickness and angle of the inclined element. The local buckling and the interaction of local and flexural buckling are studied. To end with, a design equation is proposed in accordance with the direct strength method specification for CFS structure.
Blood Biomarker Profiling and Monitoring for High-Performance Physiology and Nutrition: Current Perspectives, Limitations and Recommendations
Authors: Pedlar Charles R. , Newell John , Lewis Nathan A. 
Published: November 2019

Abstract
Blood test data were traditionally confined to the clinic for diagnostic purposes, but are now becoming more routinely used in many professional and elite high-performance settings as a physiological profiling and monitoring tool. A wealth of information based on robust research evidence can be gleaned from blood tests, including: the identification of iron, vitamin or energy deficiency; the identification of oxidative stress and inflammation; and the status of red blood cell populations. Serial blood test data can be used to monitor athletes and make inferences about the efficacy of training interventions, nutritional strategies or indeed the capacity to tolerate training load. Via a profiling and monitoring approach, blood biomarker measurement combined with contextual data has the potential to help athletes avoid injury and illness via adjustments to diet, training load and recovery strategies. Since wide inter-individual variability exists in many biomarkers, clinical population-based reference data can be of limited value in athletes, and statistical methods for longitudinal data are required to identify meaningful changes within an athlete. Data quality is often compromised by poor pre-analytic controls in sport settings. The biotechnology industry is rapidly evolving, providing new technologies and methods, some of which may be well suited to athlete applications in the future. This review provides current perspectives, limitations and recommendations for sports science and sports medicine practitioners using blood profiling and monitoring for nutrition and performance purposes.
Nutrition and Athlete Bone Health
Authors: Sale Craig , Elliott-Sale Kirsty Jayne 
Published: November 2019

Abstract
Athletes should pay more attention to their bone health, whether this relates to their longer-term bone health (e.g. risk of osteopenia and osteoporosis) or their shorter-term risk of bony injuries. Perhaps the easiest way to do this would be to modify their training loads, although this advice rarely seems popular with coaches and athletes for obvious reasons. As such, other possibilities to support the athletes’ bone health need to be explored. Given that bone is a nutritionally modified tissue and diet has a significant influence on bone health across the lifespan, diet and nutritional composition seem like obvious candidates for manipulation. The nutritional requirements to support the skeleton during growth and development and during ageing are unlikely to be notably different between athletes and the general population, although there are some considerations of specific relevance, including energy availability, low carbohydrate availability, protein intake, vitamin D intake and dermal calcium and sodium losses. Energy availability is important for optimising bone health in the athlete, although normative energy balance targets are highly unrealistic for many athletes. The level of energy availability beyond which there is no negative effect for the bone needs to be established. On the balance of the available evidence it would seem unlikely that higher animal protein intakes, in the amounts recommended to athletes, are harmful to bone health, particularly with adequate calcium intake. Dermal calcium losses might be an important consideration for endurance athletes, particularly during long training sessions or events. In these situations, some consideration should be given to pre-exercise calcium feeding. The avoidance of vitamin D deficiency and insufficiency is important for the athlete to protect their bone health. There remains a lack of information relating to the longer-term effects of different dietary and nutritional practices on bone health in athletes, something that needs to be addressed before specific guidance can be provided.